PharmaShots Weekly Snapshot (Sept 14 -18, 2020)
1. AstraZeneca Reports Updated Results of Imfinzi in P-III Studies for NSCLC and ES-SCLC
Published: Sept 18, 2020 | Tags: AstraZeneca, Reports, Updated Results, Imfinzi, P-III, Studies, NSCLC, ES-SCLC
Published: Sept 18, 2020 | Tags: Roche, Actemra, EMPACTA study, COVID-19, Pneumonia, Ventilation, Biologic, COVID-19 associated pneumonia
Published: Sept 18, 2020 | Tags: AstraZeneca, MSD, Report, Five Year, Data, Lynparza, P-III, SOLO-1, Study, 1L Maintenance Treatment, Patients, BRCA-Mutated, Ovarian Cancer
4. Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies
Published: Sept 18, 2020 | Tags: Roche, Launches, Elecsys Anti-SARS-CoV-2 S, Test, COVID-19, Antibodies
5. Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies
Published: Sept 17, 2020 | Tags: Eli Lilly, Collaborates, Amgen, Boost, Global Supply, COVID-19 Therapies
6. AstraZeneca Acquires Dogma Therapeutics Oral PCSK9 Inhibitor Program
Published: Sept 17, 2020 | Tags: AstraZeneca, Acquires, Dogma Therapeutics, Oral, PCSK9 Inhibitor Program
7. Roche to Present its Oncology Portfolio at the ESMO Virtual Congress 2020
Published: Sept 17, 2020 | Tags: Roche, Present, Oncology Portfolio, ESMO, Virtual Congress 2020
Published: Sept 16, 2020 | Tags: Junshi, Wigen, Collaborate, Develop, Commercialize, Four Therapies, Targeting, Cancer Indications
9. Sorrento to Initiate P-I Study of STI-1499 in COVID-19 Positive Patients
Published: Sept 16, 2020 | Tags: Sorrento, Initiate, P-I, Study, STI-1499, COVID-19, Positive, Patients
Published: Sept 16, 2020| Tags: Samsung Bioepis, Present, P-III, Exploratory Analyses, Results, Aybintio, bevacizumab, biosimilar, ESMO 2020
Published: Sept 17, 2020 | Tags: Novartis, Reports, Results, Dual regimen, P-III, COMBI-AD Study, Patients, Stage III Melanoma
Published: Sept 16, 2020 | Tags: Baxter, Signs, Exclusive, Distribution, Agreement, bioMérieux, Acute Kidney Injury, Diagnostic Test, US, EU
13. Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting
Published: Sept 16, 2020 | Tags: Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting
Published: Sept 15, 2020 | Tags: Roche, CINtec PLUS Cytology Test, Receives, US, FDA, Approval, Aid, Clinicians, Preventing, Cervical Cancer
15. Takeda to Divest TachoSil to Corza Health for ~$416M
Published: Sept 16, 2020 | Tags: Takeda, Divest, TachoSil, Corza Health, ~$416M
Published: Sept 15, 2020 | Tags: Gilead, Magrolimab, US FDA, Breakthrough Therapy Designation, Myelodysplastic Syndrome, 2020 European Hematology Society Congress
17. BMS Exercises its Option to Globally License Obsidian's CD40L Cell Therapy
Published: Sept 15, 2020 | Tags: BMS, Exercises, Option, Globally, License, Obsidian, CD40L Cell Therapy
18. Merck's Brenzys (biosimilar, etanercept) Receives Health Canada Approval for Multiple Indications
Published: Sept 15, 2020 | Tags: Merck, Brenzys, biosimilar, etanercept, Receives, Health Canada, Approval, Multiple, Indications
19. Boehringer Ingelheim Reports Results of BI 425809 in P-II Study for Schizophrenia
Published: Sept 14, 2020 | Tags: Boehringer Ingelheim, BI 425809, Schizophrenia, ECNP Congress, Cognitive Impairment, CNS
20. The US FDA Rejects Mallinckrodt's Terlipressin Due to Doubts in its Risk-Benefit Profile
Published: Sept 14, 2020 | Tags: US, FDA, Rejects, Mallinckrodt, Terlipressin, Doubts, Risk-Benefit Profile
Published: Sept 14, 2020 | Tags: Novartis, Beovu, brolucizumab, EMA Approval, Label Update, Safety Label, Wet AMD, Retinal Vasculitis, Retinal Vascular Occlusion, Intraocular Inflammation
Published: Sept 14, 2020 | Tags: Janssen, Collaborates, SpringWorks Therapeutics, Evaluate, Nirogacestat, Teclistamab, Relapsed, Refractory, Multiple Myeloma
Published: Sept 14, 2020 | Tags: Eli Lilly, Incyte, Olumiant, Gilead, Veklury, Reduce Time, Recovery, Hospitalized Patients, COVID-19
24. Fitbit to Launch ECG App in the US and EU in October 2020
Published: Sept 14, 2020 | Tags: Fitbit, Launch, ECG App, US, EU, October, 2020, Fitbit Sense, AFib, ECG,
25. Merck Signs Up to $4.5B Oncology Deal with Seattle Genetics
Published: Sept 14, 2020 | Tags: Merck, Signs, Up to, $4.5B, Oncology Deal, Seattle Genetics
Published: Sept 13, 2020 | Tags: Boehringer Ingelheim, Click Therapeutics, Collaborate, Digital Therapeutic, Behavior Modification, Schizophrenia
27. Novartis Reports Results of Beovu (brolucizumab) in P-III KITE Study for Diabetic Macular Edema
Published: Sept 13, 2020 | Tags: Novartis, Reports, Results, Beovu, (brolucizumab), P-III, KITE Study, Diabetic Macular Edema
Published: Sept 13, 2020 | Tags: Sanofi, Dupixent, Receives, US, FDA, Breakthrough Therapy Designation, Eosinophilic Esophagitis
29. AstraZeneca Resumes COVID-19 Vaccine Trials in the UK
Published: Sept 12, 2020 | Tags: AstraZeneca, Resumes, COVID-19 Vaccine, Trials, UK
30. Gilead to Acquire Immunomedics for ~$21B
Published: Sept 12, 2020 | Tags: Gilead, Acquire, Immunomedics, ~$21B
Related Post: PharmaShots Weekly Snapshot (Sept 07 -11, 2020)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com